Organizational determinants of outpatient substance abuse treatment duration in women.
Organizational determinants of outpatient substance abuse treatment duration in women.
复制标题
DOI：
10.1016/j.jsat.2008.09.012
复制
发表时间：
2009-07
影响因子：
3.9
通讯作者：
Lemak CH
中科院分区：
文献类型：
--
作者：
Campbell CI;Alexander JA;Lemak CH
较长的治疗持续时间一直与改善物质使用结果有关。本研究探讨了如何量身定制的妇女的编程和组织特征与持续时间在门诊药物滥用治疗的妇女。数据来自两波全国门诊药物滥用治疗单位调查（1999/2000年n=571，2005年n=566）。分别对美沙酮和非美沙酮方案进行分析。负二项回归测试之间的关联组织的决定因素，量身定制的编程，和妇女的治疗时间。量身定制的规划服务，儿童保育显着相关的非美沙酮方案的持续时间较长，但很少有其他组织因素。量身定制的编程与美沙酮项目的治疗持续时间无关，但所有权，从属关系和认证与更长的持续时间有关。研究结果表明，外部关系如何与资源，治疗的限制和合法性可能会影响妇女的治疗时间的证据。美沙酮计划可能更容易受到外部影响。
Longer treatment duration has consistently been related to improved substance use outcomes. This study examined how tailored women's programming and organizational characteristics were related to duration in outpatient substance abuse treatment in women. Data were from two waves of a national outpatient substance abuse treatment unit survey (n=571 in 1999/2000, n=566 in 2005). Analyses were conducted separately for methadone and non-methadone programs. Negative binomial regressions tested associations between organizational determinants, tailored programming, and women's treatment duration. Of the tailored programming services, childcare was significantly related to longer duration in the non-methadone programs, but few other organizational factors were. Tailored programming was not associated to treatment duration in methadone programs, but ownership, affiliation, and accreditation were related to longer duration. Study findings suggest evidence for how external relationships related to resources, treatment constraints, and legitimacy may influence women's treatment duration. Methadone programs may be more vulnerable to external influences.